OGN vs XTIA · P/E 3.4, rev $6.40B vs rev $3.2M
Organon & Co (OGN) versus XTI Aerospace, Inc. (XTIA) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
XTI Aerospace, Inc. (XTIA) is a aerospace & defense company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported XTIA revenue for 2024-12-31 was $3.2M. Net income was -$35.6M. Revenue was down 29.8% from 2023-12-31 to 2024-12-31. XTIA currently screens at market cap $69.3M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. XTIA currently screens at market cap $69.3M.
Not investment advice. Open the OGN and XTIA stock pages for the full models.
Not investment advice.